Related Experiment Video
Updated: Sep 15, 2025

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
Uterine Mesenchymal Neoplasm With BRD8::PHF1 Fusion: Low-grade Endometrial Stromal Sarcoma or Uterine Ossifying
Niall O'Neill1, James Sampson2, W Glenn McCluggage1
1Department of Pathology, Belfast Health and Social Care Trust, Belfast.
Abstract:
We report an unusual uterine polypoid mesenchymal tumor in a 52-year-old resembling the soft tissue neoplasm ossifying fibromyxoid tumor (OFMT). The neoplasm was morphologically low-grade with hypocellular areas containing bland spindle cells in a fibromyxoid stroma, cellular areas resembling typical low-grade endometrial stromal sarcoma (LGESS), and abundant mature bone. The cellular areas were ER and CD10 positive and cyclin D1 negative, and the hypocellular areas were ER and CD10 negative, with approximately 50% of the nuclei being cyclin D1 positive. The tumor harbored a BRD8::PHF1 fusion. This fusion has been reported rarely in uterine mesenchymal neoplasms, which have been designated as LGESS or high-grade endometrial stromal sarcoma. In reporting this case, we review previously reported uterine mesenchymal neoplasms with a BRD8::PHF1 fusion. Since OFMT commonly contains PHF1 fusions, we discuss the most appropriate terminology for the neoplasm we report and suggest that it is best classified as an LGESS with OFMT-like morphology.
More Related Videos
11:34Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
Published on: December 5, 2017
07:44Non-Invasive Ultrasound Assessment of Endometrial Cancer Progression in Pax8-Directed Deletion of the Tumor Suppressors Arid1a and Pten in Mice
Published on: February 17, 2023